Get a sample of the comprehensive CHEST Curriculum Pathway for Asthma with the CHEST Curriculum Pathway for Asthma: Treatment Highlights, which focuses specifically on asthma therapies and treatment. Topic areas include asthma phenotypes and biomarkers, management strategies for patients with severe asthma, and monoclonal antibodies against IL-5.

When you’ve completed the sample modules, dive into the full pathway. The CHEST Curriculum Pathway for Asthma is a collection of the best of CHEST asthma education resources. Improve your expertise in asthma diagnosis and management, and claim credit—all in one place via web and mobile device.

Access bite-sized educational resources like CHEST SEEK™ questions, videos from asthma experts, and research from the journal CHEST®. Most resources take fewer than 20 minutes to review, so you can fit asthma education into your busy schedule.

Start the sample modules by signing in with your CHEST credentials.

• Interpret the role of type 2 inflammation in asthma.
• Review targeted therapies in severe asthma.

The CHEST Curriculum Pathway for Asthma: Treatment Highlights is supported by educational grants from Genentech, a member of the Roche group, and Regeneron Pharmaceuticals.

Asthma Work Group Faculty 

Sandra G. Adams, MD, MS, FCCP - Chair

Sandhya Khurana, MD, FCCP  

Diego J. Maselli, MD, FCCP

Asthma Work Group Reviewers

Farrukh Abbas, MD, MBBS

Garbo Mak, MD

Navitha Ramesh, MD, MBBS, FCCP

The content in CHEST Curriculum Pathway for Asthma: Treatment Highlights was validated on September 20, 2022, and is accredited until September 20, 2025. In accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME), the content in this pathway is subject to regular validation review for relevancy and accuracy. As a result, pathway content can be modified, deleted, or retired by CHEST at any time to reflect new developments in medical science. The accreditation duration of content is established by the American College of Chest Physicians (CHEST) in accordance with the ACCME’s policies. 

CHEST is accredited by the ACCME to provide continuing medical education for physicians.

CHEST designates the enduring material found in the CHEST Curriculum Pathway for Asthma: Treatment Highlights sample for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of the CME activities found in the CHEST Curriculum Pathway for Asthma: Treatment Highlights collection, which include participation in the evaluation component, enable the participant to earn up to 1.0 Medical Knowledge Maintenance of Certification (MOC) point in the American Board of Internal Medicine's (ABIM) MOC program.

It is the CME activity provider's responsibility to submit participant completion information to the ACCME for the purpose of granting ABIM MOC credit.